“The attack on stem cell research has driven at least one regenerative medicine company to seek friendlier climes south of the border. Six months after the federal government forced it to stop its treatments, the Houston-based Celltex Therapeutics moved its operations to Mexico to avoid the long arm of the law. In moving to Mexico, Celltex enters a country where stem cell research is not as heavily regulated as in the U.S, though a facility is required to have an International Health Department Permit (COFEPRIS). The permit allocates the use of stem-cell types beyond those in the U.S.”
Related posts:
Can Congress stop Trump from supporting Saudi Arabia's war in Yemen?
CDC calls rising E-cigarette among teens ‘deeply troubling’
Japan's economy shrinks after sales tax hike
Julian Assange says victorious Obama ‘wolf in sheep’s clothing’
A radical dream for making techno utopias a reality
U.S. denies missile test in the Mediterranean linked to Syria
Police Fatally Shoot Okla. Man While Forcibly Rescuing Him From Flood
Growing number of educators boycott standardized tests
Emerging market rout threatens wider global economy
8-year-old girl handcuffed, jailed for two hours
Shootings by Philly police soar as violent crime plummets
Dutch court finds six coffee shop owners guilty of selling cannabis to non-residents
Nursing home staff allegedly abused elderly Alzheimer’s patients
Missouri gov. signs gun-safety course for first-graders
Ex-Goldman Sachs trader charged with $118 million trading fraud